Analyze Diet
Australian veterinary journal1983; 60(6); 180-183; doi: 10.1111/j.1751-0813.1983.tb05958.x

Evaluation of clinical and luteolytic effects of a novel prostaglandin analogue in normal and problem mares.

Abstract: Alfaprostal (K 11941), a novel prostaglandin F2 alpha analogue was clinically tested in 24 dioestrous mares, 40 anoestrous mares and 31 postpartum mares, all being given 2 or 3 mg intramuscularly. Blood samples were taken for the determination of plasma progesterone levels and the objective confirmation of luteolytic drug effects. Two hundred and thirty-six mares at the same location were used for comparisons of the rates of pregnancy, early embryonic loss and foaling. Alfaprostol was found to act as a potent luteolytic agent with good oestrus induction, follicular development and normal conception (72.6%) and foaling rate (65.3%). No side effects were observed. Treatments commenced early in the season (October), when only 35% of the anoestrous mares showed elevated progesterone levels, but in 80% of anoestrous mares with baseline progesterone levels, alfaprostol initiated heat and ovulation followed by normal fertility.
Publication Date: 1983-06-01 PubMed ID: 6626065DOI: 10.1111/j.1751-0813.1983.tb05958.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study examines the introduction of Alfaprostol, a new variant of the Prostaglandin F2 alpha hormone, in mares exhibiting different reproductive behaviors and conditions. It demonstrates the drug’s effective role as a luteolytic agent, inducing successful ovulation, conception, and birth rates without any observable adverse effects.

Objective and Methodology

  • The purpose of this research was to evaluate the luteolytic and clinical effects of Alfaprostol (K 11941), a novel prostaglandin F2 alpha analogue that was tested on mares in differing stages of their reproductive cycle.
  • A total of 95 equine subjects were part of this experiment: 24 mares in dioestrous (not fertile) stage, 40 mares in anoestrous (out of breeding season) stage, and 31 postpartum (following childbirth) mares.
  • This study utilized intramuscular administration of either 2 or 3 mg of Alfaprostol. Blood samples were taken from the mares to measure plasma progesterone levels, informing researchers of the drug’s luteolytic effects.
  • For comparative analysis, 236 similar mares were observed for rates of pregnancy, early embryonic loss, and foaling.

Findings

  • The results showed that Alfaprostol was effective as a luteolytic agent, triggering oestrus (period of fertility), follicular development (growth and maturation of egg cells), and maintaining normal conception rates of 72.6% and foaling rates of 65.3%.
  • No side effects were reported during the experiment, suggesting that Alfaprostol is a safe agent for inducing fertility in mares.
  • Starting treatments early in the breeding season (October) when only 35% of the anoestrous mares exhibited elevated progesterone levels, resulted in 80% of treated mares entering oestrus and ovulating. This subsequently led to normal fertility, underscoring the potency of Alfaprostol.

Implications

  • This study presents Alfaprostol as a promising tool in equine reproductive management. Its luteolytic properties and ability to induce productive estrus in mares could be utilized in breeding programs to increase fertility rates and successful births.
  • Further research can explore the long-term impacts and effectiveness of Alfaprostol along with its potential applications in other livestock or animals.

Cite This Article

APA
Howey WP, Jochle W, Barnes WJ. (1983). Evaluation of clinical and luteolytic effects of a novel prostaglandin analogue in normal and problem mares. Aust Vet J, 60(6), 180-183. https://doi.org/10.1111/j.1751-0813.1983.tb05958.x

Publication

ISSN: 0005-0423
NlmUniqueID: 0370616
Country: England
Language: English
Volume: 60
Issue: 6
Pages: 180-183

Researcher Affiliations

Howey, W P
    Jochle, W
      Barnes, W J

        MeSH Terms

        • Animals
        • Female
        • Horse Diseases / drug therapy
        • Horses
        • Infertility, Female / veterinary
        • Luteolytic Agents / therapeutic use
        • Ovulation Induction / veterinary
        • Pregnancy
        • Progesterone / blood
        • Prostaglandins F / therapeutic use

        Citations

        This article has been cited 0 times.